Swiss pharma giant Novartis is diving into research on ageing to tap the growing market for drugs that help keep older adults ...

Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

Weight loss injections work by making you feel fuller and less hungry. There are plenty of weight loss medication options to ...

Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending flexibilities for compounded products. The grace period for manufacturers to ...

Despite its popularity, Ozempic often leads to temporary weight loss, carries serious side effects, and most users regain ...

GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...

Americans face soaring prescription drug prices, paying far more for medications like Ozempic than patients in Europe or ...